<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_axis" title="PD-L1/PD-1 Axis in Glioblastoma Multiforme" shortTitle="axis" author="Jakub Litak, Marek Mazurek, Cezary Grochowski, Piotr Kamieniak, Jacek Roliński" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/1422-0067/20/21/5347/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
6.	LS	6.
Angiogenesis	NNP	Angiogenesis
in	IN	in
Glioblastomas	NNP	Glioblastomas
</s>
</head>
<p>
<s type="decl">
Features	NNS	feature
of	IN	of
glioblastomas	NNS	glioblastoma
are	VBP	be
a	DT	a
high	JJ	high
propensity	NN	propensity
to	TO	to
invade	VB	invade
the	DT	the
surrounding	VBG	surround
tissues	NNS	tissue
and	CC	and
extensive	JJ	extensive
angiogenesis	NN	angiogenesis
.	.	.
</s>
<s type="decl">
They	PRP	they
are	VBP	be
characterized	VBN	characterize
by	IN	by
a	DT	a
pathological	JJ	pathological
vascular	JJ	vascular
system	NN	system
with	IN	with
a	DT	a
dense	JJ	dense
network	NN	network
of	IN	of
winding	VBG	wind
vessels	NNS	vessel
of	IN	of
different	JJ	different
diameters	NNS	diameter
,	,	,
increased	VBN	increase
permeability	NN	permeability
,	,	,
and	CC	and
with	IN	with
abnormally	RB	abnormally
thickened	VBN	thicken
basement	NN	basement
membranes	NNS	membrane
.	.	.
</s>
<s type="decl">
These	DT	this
properties	NNS	property
are	VBP	be
often	RB	often
the	DT	the
cause	NN	cause
of	IN	of
relapses	NNS	relapse
and	CC	and
therapy	NN	therapy
failures	NNS	failure
because	IN	because
they	PRP	they
hinder	VBP	hinder
tumor	NN	tumor
access	NN	access
to	IN	to
cytotoxic	JJ	cytotoxic
chemotherapy	NN	chemotherapy
.	.	.
</s>
</p>
<p>
<s type="decl">
Angiogenesis	NN	angiogenesis
caused	VBN	cause
by	IN	by
the	DT	the
presence	NN	presence
of	IN	of
a	DT	a
tumor	NN	tumor
is	VBZ	be
defined	VBN	define
as	IN	as
the	DT	the
formation	NN	formation
of	IN	of
new	JJ	new
blood	NN	blood
vessels	NNS	vessel
based	VBN	base
on	IN	on
existing	VBG	exist
ones	NNS	one
,	,	,
which	WDT	which
can	MD	can
be	VB	be
visualized	VBN	visualize
using	VBG	use
ultra-high-field	JJ	ultra-high-field
magnetic	JJ	magnetic
resonance	NN	resonance
angiography	NN	angiography
.	.	.
</s>
<s type="decl">
The	DT	the
mechanism	NN	mechanism
of	IN	of
this	DT	this
process	NN	process
is	VBZ	be
very	RB	very
complex	JJ	complex
.	.	.
</s>
<s type="decl">
In	IN	in
GBM	NNP	GBM
,	,	,
the	DT	the
development	NN	development
of	IN	of
pathological	JJ	pathological
vasculature	NN	vasculature
is	VBZ	be
based	VBN	base
on	IN	on
changes	NNS	change
in	IN	in
adhesion	NN	adhesion
molecules	NNS	molecule
on	IN	on
the	DT	the
endothelial	JJ	endothelial
surface	NN	surface
,	,	,
the	DT	the
presence	NN	presence
of	IN	of
an	DT	a
erratic	JJ	erratic
basement	NN	basement
membrane	NN	membrane
,	,	,
a	DT	a
decrease	NN	decrease
in	IN	in
pericyte	JJ	pericyte
coverage	NN	coverage
,	,	,
and	CC	and
a	DT	a
weaker	JJR	weak
binding	NN	binding
of	IN	of
astrocytes	NNS	astrocyte
to	IN	to
blood	NN	blood
vessels	NNS	vessel
.	.	.
</s>
<s type="decl">
A	DT	a
common	JJ	common
element	NN	element
for	IN	for
the	DT	the
large	JJ	large
invasiveness	NN	invasiveness
and	CC	and
angiogenesis	NN	angiogenesis
of	IN	of
glioblastomas	NNS	glioblastoma
is	VBZ	be
the	DT	the
loss	NN	loss
of	IN	of
tumor	NN	tumor
cell	NN	cell
boundaries	NNS	boundary
with	IN	with
the	DT	the
surrounding	VBG	surround
microenvironment	NN	microenvironment
consisting	VBG	consist
of	IN	of
brain	NN	brain
tissue	NN	tissue
,	,	,
subarachnoid	JJ	subarachnoid
space	NN	space
,	,	,
and	CC	and
blood	NN	blood
vessels	NNS	vessel
.	.	.
</s>
</p>
<p>
<s type="decl">
Angiogenesis	NN	angiogenesis
occurs	VBZ	occur
under	IN	under
the	DT	the
influence	NN	influence
of	IN	of
various	JJ	various
mechanisms	NNS	mechanism
,	,	,
which	WDT	which
we	PRP	we
divide	VBP	divide
into	IN	into
hypoxia-dependent	JJ	hypoxia-dependent
and	CC	and
hypoxia-independent	NN	hypoxia-independent
.	.	.
</s>
<s type="decl">
Hypoxia	NNP	Hypoxia
has	VBZ	have
been	VBN	be
proven	VBN	prove
to	TO	to
inactivate	VB	inactivate
prolyl	NN	prolyl
hydroxylases	NNS	hydroxylase
.	.	.
</s>
<s type="decl">
This	DT	this
increases	VBZ	increase
the	DT	the
level	NN	level
of	IN	of
hypoxia-inducible	NN	hypoxia-inducible
factor-1α	NN	factor-1α
(	-LRB-	(
HIF-1α	NNP	HIF-1α
)	-RRB-	)
,	,	,
causing	VBG	cause
the	DT	the
release	NN	release
of	IN	of
vascular	JJ	vascular
endothelial	NN	endothelial
growth	NN	growth
factor	NN	factor
(	-LRB-	(
VEGF	NNP	VEGF
)	-RRB-	)
by	IN	by
glioma	NN	glioma
cells	NNS	cell
affected	VBN	affect
by	IN	by
hypoxia	NN	hypoxia
.	.	.
</s>
<s type="decl">
The	DT	the
task	NN	task
of	IN	of
VEGF	NNP	VEGF
is	VBZ	be
to	TO	to
counteract	VB	counteract
oxygen	NN	oxygen
deficiency	NN	deficiency
by	IN	by
inducing	VBG	induce
vascular	JJ	vascular
network	NN	network
growth	NN	growth
.	.	.
</s>
</p>
<p>
<s type="sub">
In	IN	in
spite	NN	spite
of	IN	of
this	DT	this
,	,	,
hypoxia	NN	hypoxia
may	MD	may
not	RB	not
be	VB	be
the	DT	the
only	JJ	only
trigger	NN	trigger
factor	NN	factor
for	IN	for
angiogenesis	NN	angiogenesis
.	.	.
</s>
<s type="decl">
This	DT	this
applies	VBZ	apply
particularly	RB	particularly
to	IN	to
the	DT	the
initial	JJ	initial
stages	NNS	stage
of	IN	of
carcinogenesis	NN	carcinogenesis
,	,	,
when	WRB	when
cell	NN	cell
hypoxia	NN	hypoxia
is	VBZ	be
not	RB	not
yet	RB	yet
severe	JJ	severe
.	.	.
</s>
<s type="decl">
Regulation	NN	regulation
of	IN	of
VEGF	NNP	VEGF
secretion	NN	secretion
also	RB	also
takes	VBZ	take
place	NN	place
by	IN	by
a	DT	a
mechanism	NN	mechanism
independent	JJ	independent
of	IN	of
hypoxia	NN	hypoxia
,	,	,
involving	VBG	involve
dysregulated	JJ	dysregulated
activation	NN	activation
of	IN	of
mitogenic	JJ	mitogenic
and	CC	and
survival	NN	survival
pathways	NNS	pathway
.	.	.
</s>
<s type="decl">
This	DT	this
applies	VBZ	apply
to	IN	to
phosphatidylinositol	NN	phosphatidylinositol
3-kinase	NN	3-kinase
and	CC	and
Ras/mitogen-activated	JJ	Ras/mitogen-activated
protein	NN	protein
kinase	NN	kinase
.	.	.
</s>
</p>
<p>
<s type="decl">
The	DT	the
PD-L1/PD-1	NNP	PD-L1/PD-1
axis	NN	axis
may	MD	may
also	RB	also
have	VB	have
roles	NNS	role
in	IN	in
regulating	VBG	regulate
the	DT	the
level	NN	level
of	IN	of
VEGF	NNP	VEGF
mediating	VBG	mediate
angiogenesis	NN	angiogenesis
.	.	.
</s>
<s type="decl">
In	IN	in
studies	NNS	study
conducted	VBN	conduct
by	IN	by
Shin	NNP	Shin
et	FW	et
al.	FW	al.
,	,	,
a	DT	a
positive	JJ	positive
correlation	NN	correlation
between	IN	between
PDL1	NNP	PDL1
levels	NNS	level
and	CC	and
VEGF	NNP	VEGF
expression	NN	expression
was	VBD	be
shown	VBN	show
in	IN	in
197	CD	197
patients	NNS	patient
with	IN	with
renal	JJ	renal
cell	NN	cell
carcinoma	NN	carcinoma
.	.	.
</s>
<s type="decl">
Similar	JJ	Similar
observations	NNS	observation
were	VBD	be
noted	VBN	note
by	IN	by
Song	NNP	Song
et	FW	et
al.	FW	al.
The	DT	the
study	NN	study
was	VBD	be
conducted	VBN	conduct
in	IN	in
64	CD	64
patients	NNS	patient
with	IN	with
primary	JJ	primary
glioma	NN	glioma
.	.	.
</s>
<s type="decl">
Also	RB	also
,	,	,
they	PRP	they
showed	VBD	show
that	IN	that
PD-L1	NNP	PD-L1
expression	NN	expression
levels	NNS	level
correlated	VBD	correlate
well	RB	well
with	IN	with
VEGF	NNP	VEGF
levels	NNS	level
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
not	RB	not
all	DT	all
studies	NNS	study
agreed	VBD	agree
on	IN	on
this	DT	this
point	NN	point
.	.	.
</s>
<s type="decl">
Research	NN	research
by	IN	by
Joseph	NNP	Joseph
et	NNP	et
al.	FW	al.
indicates	VBZ	indicate
the	DT	the
existence	NN	existence
of	IN	of
a	DT	a
negative	JJ	negative
relationship	NN	relationship
between	IN	between
VEGF-related	JJ	VEGF-related
genes	NNS	gene
and	CC	and
the	DT	the
activity	NN	activity
of	IN	of
the	DT	the
PD-L1/PD1	NNP	PD-L1/PD1
axis	NN	axis
.	.	.
</s>
<s type="decl">
A	DT	a
thorough	JJ	thorough
understanding	NN	understanding
of	IN	of
the	DT	the
nature	NN	nature
of	IN	of
this	DT	this
relationship	NN	relationship
requires	VBZ	require
further	JJ	further
work	NN	work
.	.	.
</s>
</p>
<p>
<s type="decl">
EGF	NNP	EGF
is	VBZ	be
another	DT	another
molecule	NN	molecule
with	IN	with
similar	JJ	similar
effects	NNS	effect
.	.	.
</s>
<s type="decl">
It	PRP	it
promotes	VBZ	promote
tumor	NN	tumor
angiogenesis	NN	angiogenesis
as	RB	as
well	RB	well
as	IN	as
an	DT	a
increase	NN	increase
in	IN	in
cell	NN	cell
motility	NN	motility
and	CC	and
invasiveness	NN	invasiveness
.	.	.
</s>
<s type="decl">
This	DT	this
is	VBZ	be
done	VBN	do
by	IN	by
phosphorylating	VBG	phosphorylate
the	DT	the
EGFR	NNP	EGFR
receptor	NN	receptor
and	CC	and
activating	VBG	activate
further	NN	further
signaling	VBG	signal
pathways	NNS	pathway
.	.	.
</s>
<s type="decl">
It	PRP	it
has	VBZ	have
been	VBN	be
shown	VBN	show
that	IN	that
both	CC	both
EGFR	NNP	EGFR
and	CC	and
its	PRP$	its
mutated	VBN	mutate
form	NN	form
of	IN	of
EGFRvIII	NNP	EGFRvIII
promote	VBP	promote
GBM	NNP	GBM
angiogenesis	NN	angiogenesis
.	.	.
</s>
<s type="decl">
To	TO	to
allow	VB	allow
vasculature	NN	vasculature
growth	NN	growth
and	CC	and
tumor	NN	tumor
invasion	NN	invasion
,	,	,
it	PRP	it
is	VBZ	be
necessary	JJ	necessary
to	TO	to
reduce	VB	reduce
the	DT	the
integrity	NN	integrity
of	IN	of
the	DT	the
tumor	NN	tumor
microenvironment	NN	microenvironment
.	.	.
</s>
<s type="decl">
The	DT	the
pathophysiology	NN	pathophysiology
of	IN	of
this	DT	this
process	NN	process
is	VBZ	be
based	VBN	base
on	IN	on
EGFR	NNP	EGFR
inducing	VBG	induce
an	DT	a
increase	NN	increase
in	IN	in
the	DT	the
activity	NN	activity
of	IN	of
some	DT	some
proteases	NNS	protease
,	,	,
thereby	RB	thereby
causing	VBG	cause
the	DT	the
breakdown	NN	breakdown
of	IN	of
collagen	NN	collagen
,	,	,
fibronectin	NN	fibronectin
,	,	,
and	CC	and
other	JJ	other
basement	NN	basement
membrane	NN	membrane
structures	NNS	structure
.	.	.
</s>
<s type="decl">
The	DT	the
result	NN	result
is	VBZ	be
a	DT	a
loss	NN	loss
of	IN	of
microenvironment	NN	microenvironment
integrity	NN	integrity
,	,	,
an	DT	a
increase	NN	increase
in	IN	in
tumor	NN	tumor
cell	NN	cell
invasion	NN	invasion
into	IN	into
surrounding	VBG	surround
tissues	NNS	tissue
and	CC	and
vessels	NNS	vessel
,	,	,
and	CC	and
an	DT	a
increase	NN	increase
in	IN	in
angiogenesis	NN	angiogenesis
.	.	.
</s>
<s type="decl">
The	DT	the
proteases	NNS	protease
whose	WP$	whose
activity	NN	activity
is	VBZ	be
influenced	VBN	influence
by	IN	by
EGFR	NNP	EGFR
include	VBP	include
,	,	,
among	IN	among
others	NNS	other
:	:	:
</s>
<list>
<item>
<s type="frag">
Serine	NNP	Serine
Proteases	NNP	Proteases
</s>
</item>
<item>
<s type="frag">
Matrix	NNP	Matrix
Metalloproteases	NNPS	Metalloproteases
(	-LRB-	(
MMPs	NNP	MMP
)	-RRB-	)
</s>
</item>
<item>
<s type="frag">
Cysteine	NNP	Cysteine
Proteases	NNPS	Proteases
.	.	.
</s>
</item>
</list>
</p>
<p>
<s type="decl">
Serine	NN	serine
proteases	NNS	protease
are	VBP	be
a	DT	a
large	JJ	large
group	NN	group
of	IN	of
proteases	NNS	protease
which	WDT	which
include	VBP	include
tissue	NN	tissue
plasminogen	NN	plasminogen
activator	NN	activator
(	-LRB-	(
tPA	NNP	tPA
)	-RRB-	)
and	CC	and
urokinase	NN	urokinase
plasminogen	NN	plasminogen
activator	NN	activator
(	-LRB-	(
uPA	NNP	uPA
)	-RRB-	)
with	IN	with
its	PRP$	its
receptor	NN	receptor
(	-LRB-	(
uPAR	NNP	uPAR
)	-RRB-	)
.	.	.
</s>
<s type="decl">
Their	PRP$	their
activation	NN	activation
affects	VBZ	affect
the	DT	the
degradation	NN	degradation
of	IN	of
the	DT	the
extracellular	JJ	extracellular
space	NN	space
by	IN	by
tumors	NNS	tumor
,	,	,
promoting	VBG	promote
their	PRP$	their
invasiveness	NN	invasiveness
.	.	.
</s>
<s type="decl">
It	PRP	it
has	VBZ	have
been	VBN	be
shown	VBN	show
that	IN	that
,	,	,
the	DT	the
PAI-1	NNP	PAI-1
molecule	NN	molecule
mediates	VBZ	mediate
the	DT	the
regulation	NN	regulation
of	IN	of
the	DT	the
uPA/uPAR	NN	uPA/uPAR
pathway	NN	pathway
in	IN	in
astrocytoma	NN	astrocytoma
cells	NNS	cell
.	.	.
</s>
<s type="decl">
Its	PRP$	its
expression	NN	expression
is	VBZ	be
promoted	VBN	promote
by	IN	by
an	DT	a
increase	NN	increase
in	IN	in
EGF	NNP	EGF
and	CC	and
inflammatory	JJ	inflammatory
cytokines	NNS	cytokine
.	.	.
</s>
<s type="decl">
This	DT	this
results	VBZ	result
in	IN	in
greater	JJR	great
uPA/uPAR	NN	uPA/uPAR
activity	NN	activity
,	,	,
thus	RB	thus
increasing	VBG	increase
tumor	NN	tumor
invasiveness	NN	invasiveness
.	.	.
</s>
</p>
<p>
<s type="decl">
Upregulation	NN	upregulation
of	IN	of
uPA	NN	uPA
and	CC	and
uPAR	NN	uPAR
is	VBZ	be
also	RB	also
achieved	VBN	achieve
through	IN	through
the	DT	the
expression	NN	expression
of	IN	of
the	DT	the
EGFR	NNP	EGFR
ligand	NN	ligand
transforming	VBG	transform
growth	NN	growth
factor	NN	factor
(	-LRB-	(
TGFα	NNP	TGFα
)	-RRB-	)
.	.	.
</s>
<s type="decl">
Studies	NNS	Study
confirmed	VBD	confirm
that	IN	that
in	IN	in
malignant	JJ	malignant
gliomas	NNS	glioma
,	,	,
both	CC	both
PAI-1	NN	PAI-1
and	CC	and
EGFR	NNP	EGFR
activity	NN	activity
correlate	VBP	correlate
with	IN	with
higher	JJR	high
tumor	NN	tumor
malignancy	NN	malignancy
and	CC	and
worse	JJR	bad
prognosis	NN	prognosis
for	IN	for
patients	NNS	patient
.	.	.
</s>
</p>
<p>
<s type="decl">
EGF	NNP	EGF
also	RB	also
has	VBZ	have
a	DT	a
potential	JJ	potential
impact	NN	impact
on	IN	on
another	DT	another
group	NN	group
of	IN	of
proteases	NNS	protease
,	,	,
i.e.	FW	i.e.
,	,	,
MMPs	NNPS	MMP
.	.	.
</s>
<s type="decl">
They	PRP	they
are	VBP	be
a	DT	a
large	JJ	large
group	NN	group
of	IN	of
enzymes	NNS	enzyme
whose	WP$	whose
effect	NN	effect
is	VBZ	be
based	VBN	base
on	IN	on
the	DT	the
regulation	NN	regulation
of	IN	of
metabolism	NN	metabolism
and	CC	and
cell	NN	cell
morphogenesis	NN	morphogenesis
.	.	.
</s>
<s type="decl">
Disruption	NN	disruption
of	IN	of
their	PRP$	their
function	NN	function
also	RB	also
affects	VBZ	affect
the	DT	the
loss	NN	loss
of	IN	of
cell	NN	cell
integrity	NN	integrity
.	.	.
</s>
<s type="decl">
It	PRP	it
has	VBZ	have
been	VBN	be
shown	VBN	show
that	IN	that
the	DT	the
activity	NN	activity
of	IN	of
certain	JJ	certain
matrix	NN	matrix
metalloproteases	NNS	metalloprotease
,	,	,
such	JJ	such
as	IN	as
MMP-2	NNP	MMP-2
(	-LRB-	(
gelatinase	NNP	gelatinase
A	CD	a
)	-RRB-	)
,	,	,
MMP-9	NNP	MMP-9
(	-LRB-	(
gelatinase	NN	gelatinase
B	NNP	B
)	-RRB-	)
,	,	,
MMP-14	NNP	MMP-14
(	-LRB-	(
matrix	NN	matrix
metalloproteinase	NN	metalloproteinase
14	CD	14
)	-RRB-	)
is	VBZ	be
related	JJ	related
to	IN	to
the	DT	the
pathophysiology	NN	pathophysiology
of	IN	of
high-grade	JJ	high-grade
gliomas	NNS	glioma
.	.	.
</s>
<s type="decl">
It	PRP	it
correlates	VBZ	correlate
with	IN	with
the	DT	the
severity	NN	severity
of	IN	of
tumor	NN	tumor
invasion	NN	invasion
and	CC	and
its	PRP$	its
degree	NN	degree
of	IN	of
malignancy	NN	malignancy
.	.	.
</s>
</p>
<p>
<s type="decl">
Another	DT	another
group	NN	group
of	IN	of
proteases	NNS	protease
are	VBP	be
cysteine	NN	cysteine
proteases	NNS	protease
,	,	,
examples	NNS	example
of	IN	of
which	WDT	which
are	VBP	be
cathepsins	NNS	cathepsin
.	.	.
</s>
<s type="decl">
These	DT	this
include	VBP	include
,	,	,
among	IN	among
others	NNS	other
,	,	,
cathepsin	NN	cathepsin
B	NNP	B
,	,	,
involved	VBN	involve
in	IN	in
the	DT	the
degradation	NN	degradation
of	IN	of
the	DT	the
tumor	NN	tumor
microenvironment	NN	microenvironment
.	.	.
</s>
<s type="decl">
Its	PRP$	its
expression	NN	expression
(	-LRB-	(
mRNA	NN	mRNA
level	NN	level
)	-RRB-	)
has	VBZ	have
been	VBN	be
shown	VBN	show
to	TO	to
correlate	VB	correlate
with	IN	with
EGFR	NNP	EGFR
expression	NN	expression
level	NN	level
.	.	.
</s>
<s type="decl">
It	PRP	it
was	VBD	be
also	RB	also
confirmed	VBN	confirm
that	IN	that
its	PRP$	its
presence	NN	presence
is	VBZ	be
increased	VBN	increase
in	IN	in
gliomas	NNS	glioma
.	.	.
</s>
<s type="sub">
The	DT	the
action	NN	action
of	IN	of
cathepsin	NN	cathepsin
B	NN	B
may	MD	may
be	VB	be
bidirectional	JJ	bidirectional
.	.	.
</s>
<s type="decl">
It	PRP	it
promotes	VBZ	promote
the	DT	the
degradation	NN	degradation
of	IN	of
the	DT	the
integrity	NN	integrity
of	IN	of
the	DT	the
environment	NN	environment
of	IN	of
the	DT	the
tumor	NN	tumor
directly	RB	directly
or	CC	or
through	IN	through
intermediate	JJ	intermediate
mediators	NNS	mediator
such	JJ	such
as	IN	as
uPA	NN	uPA
,	,	,
MMPs	NNS	MMP
,	,	,
or	CC	or
plasmin	NN	plasmin
.	.	.
</s>
</p>
</text>